| Document |
Document Title |
|
WO/2011/061220A1 |
The present invention relates to Melamine based Mannich compounds of the general formulae (1 )-(12) and a process for synthesizing melamine based Mannich-products products comprising the steps of a) reacting at least one substituted mela...
|
|
WO/2011/057597A1 |
The invention relates to a gas scrubber, equipped with heat exchanger surfaces constructed from thermal sheets, suitable for cooling and purifying a hot gas, while avoiding excessive thermal loading of the scrubbing liquid.
|
|
WO/2011/057596A1 |
The invention relates to a method for continuously producing melamine from urea by means of a fluidized bed reactor, wherein process gas conducted in the process circuit is used as the fluidizing gas, and wherein the temperature of the p...
|
|
WO/2011/055914A1 |
Organic electroluminescent compounds of Chemical Formula 1 : wherein the variables A1, A2, A3, A4, A5, (L1)n, R1 and R2 are as defined therein in the specification. These compounds exhibit high luminous efficiency and excellent life prop...
|
|
WO/2011/049241A1 |
Disclosed is an organic electroluminescent element which comprises: an anode; a cathode; a light-emitting layer that is arranged between the anode and the cathode and contains a first light-emitting layer material that contains a phospho...
|
|
WO/2011/047323A2 |
The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and ani...
|
|
WO/2011/042532A1 |
The present invention relates to a method for recycling water in a melamine production process comprising - a wet process comprising the steps of aqueous treatment of a melamine melt from a melamine synthesis plant with an aqueous alkali...
|
|
WO/2011/039735A2 |
The present invention relates to the medical use of the compound of formula 1, 2, 3 or 4:
|
|
WO/2011/040984A1 |
A method for producing a β-enriched protected decitabine comprising: a) coupling a protected 2-deoxy-ribofuranose with a protected 5-azacytosine in the presence of a catalyst to form a reaction mixture comprising the protected decitabin...
|
|
WO/2011/033066A2 |
The present invention- relates to the use of specific disulfo-type fluorescent whitening agents for optically brightening coating slips containing a synthetic binder and a different synthetic co-binder. Further, the invention relates to ...
|
|
WO/2011/033062A2 |
The present invention relates to the use of concentrated aqueous fluorescent whitening agent preparations for optically whitening paper, wherein the preparation contains a specific disulfo-type fluorescent whitening agent.
|
|
WO/2011/033064A2 |
The present invention relates to fluorescent whitening agent compositions containing at least two specific disulfo-type fluorescent whitening agents for optically whitening paper or board.
|
|
WO/2011/026835A1 |
The present invention relates to novel hepcidine antagonists of the formula (I), comprising pharmaceutical compositions and the use thereof as medications, in particular for treating iron metabolism disorders, such as in particular iron ...
|
|
WO/2011/022715A1 |
A light-emitting polymer composition includes a polysiloxane polymer having tritium that emits radiation and a wavelength-shifter chemically bonded to the polysiloxane polymer or a siloxane carrier dispersed within the polysiloxane polym...
|
|
WO/2011/021689A1 |
Disclosed is a cyclic azine derivative represented by general formula (1). This cyclic azine derivative is useful as an organic-compound layer in fluorescence-type and phosphorescence-type organic electroluminescent elements. [In formula...
|
|
WO/2011/018742A1 |
The invention provides compounds of formula (I), in which R1 and R2 are independently selected from H, alkyl, aryl and heteroaryl, or R1 and R2 together form a C5-C7 ring, R3-R7 are independently selected from H, halogen, alkyl and alkox...
|
|
WO/2011/013723A1 |
Provided is a new triazine compound that protects against ultraviolet rays even in a long-wavelength region and is useful as an ultraviolet absorber with superior light resistance. Also provided are an ultraviolet absorber that maintains...
|
|
WO/2011/010953A1 |
The invention relates to the technique for producing melamine as a whole by converting carbamide into melamine using a non-catalytic method at high pressure, as well as to a stage of removing dissolved gases from an aqueous solution of u...
|
|
WO/2011/010843A1 |
The present invention relates to organic electroluminescent compounds and an organic electroluminescent device using the same. The organic electroluminescent compound accordingly to the present invention is represented by Chemical Formul...
|
|
WO/2010/151006A1 |
Provided are a novel organic electroluminescent compound and an organic electroluminescent device using the same. Since the organic electroluminescent compound disclosed herein exhibits good luminescence efficiency and excellent life pro...
|
|
WO/2010/137518A1 |
A corrosion-causing substance contained in triallylisocyanurate is identified among impurities in triallylisocyanurate to produce triallylisocyanurate containing a less amount of the corrosion-causing substance. Thus, disclosed is triall...
|
|
WO/2010/137517A1 |
A corrosion-causing substance contained in triallylisocyanurate is identified among impurities in triallylisocyanurate to produce triallylisocyanurate containing the corrosion-causing substance in less amount. Thus, disclosed is triallyl...
|
|
WO/2010/137519A1 |
Disclosed is a method for storing triallyl isocyanurate (TAIC) whereby freezing and solidification of TAIC during storage in winter season can be prevented. TAIC is mixed with a silane coupling agent and stored in the form of a mixture o...
|
|
WO/2010/130311A1 |
Tanned leather, skin or pelt is produced by non-metal tanning, comprising the step of tanning with a tanning agent (A) of formula (I), wherein Hal signifies fluorine or chlorine, R1 signifies hydrogen, C1-8-alkyl or an alkyleneoxy radica...
|
|
WO/2010/127805A1 |
The invention relates to triazine-based special organic UV absorbers modified in such a way as to be soluble in polar coating compositions. The invention further relates to coatings, e.g. sol-gel based ones, containing said novel UV abso...
|
|
WO/2010/128660A1 |
Disclosed is a carbon nanotube dispersing/solubilizing agent which is composed of a hyperbranched polymer that contains a triazine ring represented, for example, by formula (14), (15) or (16) as a repeating unit and has a weight average ...
|
|
WO/2010/129211A2 |
The present application relates to processes for the preparation and purification of decitabine, and to processes for the preparation of a crystalline form of decitabine.
|
|
WO/2010/125611A1 |
A flame retardant composition for flammable plastic materials and a method for producing the same are disclosed. The flame retardant composition comprises 2,4,6-tris(2,4,6-tribromophenoxy)-1,3,5- triazine that contains 1 to 1000ppm of a ...
|
|
WO/2010/118187A2 |
A method of modifying a particle that includes reacting a reactive compound having an X-[Y]n reactive group with a secondary compound N-S-ZM to form a substituted reactive intermediate [Y]a-X-(N-S-ZM)b, and reacting the particle with the...
|
|
WO2010109851A1 |
Disclosed is a novel lubricant composition which is useful as a material for a lubrication layer in a magnetic recording medium. The lubricant composition contains at least one compound represented by formula (1). In the formula, X repre...
|
|
WO/2010/109015A1 |
A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.
|
|
WO/2010/108583A1 |
The invention relates to a method for chromatographically separating compounds of the formula (I), where R1, R2, R3, R4, R5, and R6 have the meanings indicated in Claim 1, and the acid addition salts thereof, characterized in that the se...
|
|
WO/2010/092966A1 |
Disclosed is a novel compound having P2X3 or P2X2/3 receptor antagonistic effect. Specifically disclosed is a compound represented by formula (I). (In the formula, (a) Ra and Rb combine together to form =Z, and Rc is a group represented...
|
|
WO/2010/085246A1 |
The invention is directed to compounds of formula (I): that modulate, e.g., inhibit, aggrecanase proteolytic activity, which is implicated in joint diseases including osteoarthritis, joint injury, reactive arthritis, acute pyrophosphate ...
|
|
WO/2010/073660A1 |
Provided are a semiconductor device which has good electrical connection properties and bond strength by suppressing the occurrence of resin burrs, and a method for producing the same. Also provided is an LED device having good light em...
|
|
WO/2010/066901A2 |
The invention relates to compounds of formula (I) wherein the radicals R1 to R6 have the meaning according to claim 1, and/or physiologically acceptable salts thereof, for the prophylactic or therapeutic treatment and/or monitoring of ph...
|
|
WO/2010/067894A1 |
Provided is an organic light emitting device having a long continuous driving lifetime. The organic light emitting device includes an anode, a cathode, and an organic compound layer which is sandwiched between the anode and the cathode, ...
|
|
WO/2010/066683A1 |
The present invention relates to a method for producing triazine carbamates by reacting at least one triazine with at least one chloroformate in the presence of at least one alkali metal compound or alkaline earth metal compound, wherein...
|
|
WO/2010/062416A1 |
Certain embodiments described herein are directed to silane coupling agents that may be used, for example, to covalently couple a polymer to a filler. In some examples, devices that include the polymer-silane coupling agent-filler compos...
|
|
WO/2010/059418A1 |
The invention provides for novel triazine and purine compounds ( II ) that are useful for the treatment and prevention of mammalian protozoal diseases, including Af rican trypanosomiasis and Chagas disease.
|
|
WO/2010/058995A1 |
Provided is an electroluminescent device comprising an organic layer interposed between an anode and a cathode on a substrate, wherein the organic layer includes an electroluminescent layer containing one or more dopant compound (s), and...
|
|
WO/2010/057851A1 |
The present invention relates to flame retardant polymer compositions which comprise melamine phenylphosphinates and mixtures with dihydro-oxa-phosphaphenanthrene derivatives. The compositions are especially useful for the manufacture of...
|
|
WO/2010/057220A1 |
A method for making diazo-compounds, diazonium salts thereof and other protected forms of these compounds. Diaz-compounds are prepared by reaction of a tertiary phosphine reagent carrying a reactive carbonyl group with an azide. The reac...
|
|
WO/2010/052569A2 |
The invention relates to novel therapeutic agents and diagnostic probes. The invention also relates to phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor triazine-, pyrimidine- and pyridine-based compound...
|
|
WO/2010/050779A1 |
Provided are novel organic electroluminescent compounds, and organic electroluminescent devices and organic solar cells comprising the same. The organic electroluminescent compounds according to the present invention exhibit high luminou...
|
|
WO/2010/046327A1 |
The invention relates to a method for producing colourless polyisocyanates, in particular to reducing the colour of polyisocyanates.
|
|
WO/2010/041559A1 |
A polymer compound having a repeating unit represented by formula (1-0). (In formula (1-0), ring A01 and ring A02 may be the same or different and each represents an optionally substituted aromatic hydrocarbon ring; and X10 and X20 may b...
|
|
WO/2010/029926A1 |
A lighting cover composed of a resin composition containing an ultraviolet absorbent (A), wherein the ultraviolet absorbent (A) is composed of a compound represented by general formula (1). (In the formula, Het1 represents a divalent 5- ...
|
|
WO/2010/024225A1 |
A compound represented by general formula (1), a tautomer thereof, or a salt of the compound or tautomer, which is useful as a bactericide/disinfectant. (In the formula, R1 represents a hydrogen atom, an optionally substituted alkyl grou...
|
|
WO/2010/014883A2 |
Processes for preparing azacitidine. Further included are processes for the preparation of crystalline azacitidine crystalline Form (I) and mixtures of azacitidine crystalline Forms (I) and (II).
|
